Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;188(4):401-407.
doi: 10.1007/s11046-023-00768-4. Epub 2023 Jun 30.

Breakthrough Invasive Sinusitis by Hormographiella aspergillata in a Neutropenic Patient Receiving Voriconazole Therapy: A Case Report and Review of Breakthrough H. aspergillata Infections

Ariel Fernando Florez-Riaño  1 , Isabel Cristina Ramírez-Sánchez  2   3
Affiliations
Review

Breakthrough Invasive Sinusitis by Hormographiella aspergillata in a Neutropenic Patient Receiving Voriconazole Therapy: A Case Report and Review of Breakthrough H. aspergillata Infections

Ariel Fernando Florez-Riaño et al. Mycopathologia. 2023 Aug.

Abstract

Breakthrough invasive infections occurs during the use of antifungals both in prophylaxis and therapy, it favors the emergence of new pathogens in the fungal landscape. Hormographiella aspergillata is considered a rare but emerging pathogen in the era of broad-spectrum antifungal use in patients with hematological malignancies. Here, we present a case report of invasive sinusitis due to Hormographiella aspergillata, manifesting as a breakthrough infection in a patient with severe aplastic anemia under treatment with voriconazole for invasive pulmonary aspergilosis. Also, we make a review of H. aspergillata breakthrough infections published in the literature.

Keywords: Antifungal; Breakthrough; Hormographiella aspergillata; Neutropenia; Sinusitis.

PubMed Disclaimer

References

    1. Kontoyiannis DP, Patterson TF. Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions. Clin Infect Dis. 2014;59(suppl_5):S356–9. https://doi.org/10.1093/cid/ciu591 . - DOI - PubMed - PMC
    1. Lekakis LJ, Lawson A, Prante J, et al. Fatal Rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature. Biol Blood Marrow Transpl. 2009;15:991–5. https://doi.org/10.1016/j.bbmt.2009.04.007 . - DOI
    1. Lamoth F, Chung SJ, Damonti L, Alexander BD. Changing epidemiology of invasive mold infections in patients receiving azole prophylaxis. Clin Infect Dis. 2017;54(11):1619–21. https://doi.org/10.1093/cid/cix130 . - DOI
    1. Brandt ME. Filamentous basidiomycetes in the clinical laboratory. Curr Fungal Infect Rep. 2013;7(3):219–23. https://doi.org/10.1007/s12281-013-0148-8 . - DOI - PubMed - PMC
    1. Ramirez IC, Agredo D, Arango K. Breakthrough Hormographiella aspergillata infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis: a case report and review. Mycopathologia. 2020;185:1069–76. https://doi.org/10.1007/s11046-020-00488-z . - DOI

Supplementary concepts

LinkOut - more resources